-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Viruses -X- _ O
are -X- _ O
increasingly -X- _ O
recognized -X- _ O
as -X- _ O
major -X- _ O
causes -X- _ O
of -X- _ O
community-acquired -X- _ O
pneumonia -X- _ O
( -X- _ O
CAP -X- _ O
) -X- _ O
. -X- _ O
Few -X- _ O
studies -X- _ O
have -X- _ O
investigated -X- _ O
the -X- _ O
clinical -X- _ O
predictors -X- _ O
of -X- _ O
viral -X- _ B-Patient
pneumonia -X- _ I-Patient
, -X- _ O
and -X- _ O
the -X- _ O
results -X- _ O
have -X- _ O
been -X- _ O
inconsistent. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
the -X- _ O
clinical -X- _ O
predictors -X- _ O
of -X- _ O
viral -X- _ B-Patient
pneumonia -X- _ I-Patient
were -X- _ O
investigated -X- _ O
in -X- _ O
terms -X- _ O
of -X- _ O
their -X- _ O
utility -X- _ O
as -X- _ O
indicators -X- _ O
for -X- _ O
viral -X- _ B-Patient
pneumonia -X- _ I-Patient
in -X- _ I-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
CAP. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
Adult -X- _ B-Patient
patients -X- _ I-Patient
( -X- _ I-Patient
≥18 -X- _ I-Patient
years -X- _ I-Patient
old -X- _ I-Patient
) -X- _ I-Patient
with -X- _ I-Patient
CAP -X- _ I-Patient
, -X- _ O
tested -X- _ O
by -X- _ O
polymerase -X- _ O
chain -X- _ O
reaction -X- _ O
( -X- _ O
PCR -X- _ O
) -X- _ O
for -X- _ O
respiratory -X- _ O
virus -X- _ O
, -X- _ O
at -X- _ O
two -X- _ O
teaching -X- _ O
hospitals -X- _ O
between -X- _ O
October -X- _ O
2010 -X- _ O
and -X- _ O
May -X- _ O
2013 -X- _ O
, -X- _ O
were -X- _ O
identified -X- _ O
retrospectively. -X- _ O
Demographic -X- _ O
and -X- _ O
clinical -X- _ O
data -X- _ O
were -X- _ O
collected -X- _ O
by -X- _ O
reviewing -X- _ O
the -X- _ O
hospital -X- _ O
electronic -X- _ O
medical -X- _ O
records. -X- _ O
RESULTS -X- _ O
: -X- _ O
During -X- _ O
the -X- _ O
study -X- _ O
period -X- _ O
, -X- _ O
456 -X- _ B-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
CAP -X- _ I-Patient
were -X- _ O
identified -X- _ O
who -X- _ O
met -X- _ O
the -X- _ O
definition -X- _ O
, -X- _ O
and -X- _ O
327 -X- _ O
( -X- _ O
72 -X- _ O
% -X- _ O
) -X- _ O
patients -X- _ O
were -X- _ O
tested -X- _ O
using -X- _ O
the -X- _ O
respiratory -X- _ O
virus -X- _ O
PCR -X- _ O
detection -X- _ O
test. -X- _ O
Viral -X- _ B-Outcome
pneumonia -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
60 -X- _ I-Outcome
) -X- _ I-Outcome
was -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
rhinorrhea -X- _ I-Outcome
, -X- _ I-Outcome
a -X- _ I-Outcome
higher -X- _ I-Outcome
lymphocyte -X- _ I-Outcome
fraction -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
white -X- _ I-Outcome
blood -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
lower -X- _ I-Outcome
serum -X- _ I-Outcome
creatinine -X- _ I-Outcome
and -X- _ I-Outcome
ground-glass -X- _ I-Outcome
opacity -X- _ I-Outcome
( -X- _ I-Outcome
GGO -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
radiology -X- _ I-Outcome
results -X- _ I-Outcome
, -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
non-viral -X- _ I-Outcome
pneumonia -X- _ I-Outcome
( -X- _ I-Outcome
n -X- _ I-Outcome
= -X- _ I-Outcome
250 -X- _ I-Outcome
) -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.05 -X- _ I-Outcome
, -X- _ I-Outcome
each -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
In -X- _ I-Outcome
a -X- _ I-Outcome
multivariate -X- _ I-Outcome
analysis -X- _ I-Outcome
, -X- _ I-Outcome
rhinorrhea -X- _ I-Outcome
( -X- _ I-Outcome
Odd -X- _ I-Outcome
ratio -X- _ I-Outcome
( -X- _ I-Outcome
OR -X- _ I-Outcome
) -X- _ I-Outcome
3.52 -X- _ I-Outcome
; -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
Confidence -X- _ I-Outcome
interval -X- _ I-Outcome
( -X- _ I-Outcome
CI -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
1.58–7.87 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
GGO -X- _ I-Outcome
( -X- _ I-Outcome
OR -X- _ I-Outcome
4.68 -X- _ I-Outcome
; -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
, -X- _ I-Outcome
2.48–8.89 -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
revealed -X- _ I-Outcome
as -X- _ I-Outcome
independent -X- _ I-Outcome
risk -X- _ I-Outcome
factors -X- _ I-Outcome
for -X- _ I-Outcome
viral -X- _ I-Outcome
pneumonia -X- _ I-Outcome
in -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
CAP. -X- _ I-Outcome
The -X- _ I-Outcome
sensitivity -X- _ I-Outcome
, -X- _ I-Outcome
specificity -X- _ I-Outcome
, -X- _ I-Outcome
positive- -X- _ I-Outcome
and -X- _ I-Outcome
negative-predictive -X- _ I-Outcome
values -X- _ I-Outcome
( -X- _ I-Outcome
PPV -X- _ I-Outcome
and -X- _ I-Outcome
NPV -X- _ I-Outcome
) -X- _ I-Outcome
of -X- _ I-Outcome
rhinorrhea -X- _ I-Outcome
were -X- _ I-Outcome
22 -X- _ I-Outcome
, -X- _ I-Outcome
91 -X- _ I-Outcome
, -X- _ I-Outcome
36 -X- _ I-Outcome
and -X- _ I-Outcome
83 -X- _ I-Outcome
% -X- _ I-Outcome
: -X- _ I-Outcome
the -X- _ I-Outcome
sensitivity -X- _ I-Outcome
, -X- _ I-Outcome
specificity -X- _ I-Outcome
, -X- _ I-Outcome
PPV -X- _ I-Outcome
and -X- _ I-Outcome
NPV -X- _ I-Outcome
of -X- _ I-Outcome
GGO -X- _ I-Outcome
were -X- _ I-Outcome
and -X- _ I-Outcome
43 -X- _ I-Outcome
, -X- _ I-Outcome
84 -X- _ I-Outcome
, -X- _ I-Outcome
40 -X- _ I-Outcome
and -X- _ I-Outcome
86 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
respectively. -X- _ I-Outcome
CONCLUSION -X- _ O
: -X- _ O
Symptom -X- _ B-Outcome
of -X- _ I-Outcome
rhinorrhea -X- _ I-Outcome
and -X- _ I-Outcome
GGO -X- _ I-Outcome
predicted -X- _ I-Outcome
viral -X- _ I-Outcome
pneumonia -X- _ I-Outcome
in -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
CAP. -X- _ I-Outcome
The -X- _ I-Outcome
high -X- _ I-Outcome
specificity -X- _ I-Outcome
of -X- _ I-Outcome
rhinorrhea -X- _ I-Outcome
and -X- _ I-Outcome
GGO -X- _ I-Outcome
suggested -X- _ I-Outcome
that -X- _ I-Outcome
these -X- _ I-Outcome
could -X- _ I-Outcome
be -X- _ I-Outcome
useful -X- _ I-Outcome
indicators -X- _ I-Outcome
for -X- _ I-Outcome
empirical -X- _ I-Outcome
antiviral -X- _ I-Outcome
therapy -X- _ I-Outcome
. -X- _ O

